Regardless of the merits of the shorter's arguments, MSB at $2 billion + is priced for some degree of success.
If there are hiccups (as there are with most biotechs), the consequences are going to be very spectacular.
Disclaimer: have watched MSB with great envy from the sidelines.
Regardless of the merits of the shorter's arguments, MSB at $2...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
91.5¢ |
Change
-0.055(5.67%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 95.0¢ | 91.0¢ | $2.776M | 2.970M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 182354 | 91.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 77455 | 5 |
View Market Depth
| Last trade - 11.24am 05/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |